ASTS
AST SpaceMobile, Inc.
ASTS trails on the overall score without a compensating advantage in the available component scores.
BRZE
Braze, Inc.
BRZE has the edge over ASTS overall, supported by stronger fundamentals and stronger modeled upside.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
BRZE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Healthy | |
| Unavailable |
BRZE's revenue and cash flow are currently healthy, but its profitability is under pressure. There isn't enough data to rate its balance sheet.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
BRZE PE Valuation
BRZE has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
BRZE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect strong earnings and revenue growth for BRZE, with profitability improving.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
BRZE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.89 | — |
| Q3 2026 | -$1.03 | +$0.01 |
| Q2 2026 | -$1.12 | -$0.11 |
| Q1 2026 | -$1.22 | -$0.20 |
| Q4 2025 | -$1.10 | +$0.03 |
| Q3 2025 | -$1.04 | +$0.13 |
| Q2 2025 | -$1.01 | +$0.26 |
| Q1 2025 | -$1.02 | +$0.30 |
| Q4 2024 | -$1.13 | +$0.26 |
BRZE has the edge over ASTS on earnings, with more consistent year-over-year improvement.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS's revenue has grown year over year for 11 quarters in a row: $42M last quarter, up 187% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
BRZE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $227.2M | +26% |
| Q2 2026 | $211M | +30% |
| Q1 2026 | $205.2M | +28% |
| Q4 2025 | $190.8M | +26% |
| Q3 2025 | $180.1M | +24% |
| Q2 2025 | $162.1M | +20% |
| Q1 2025 | $160.4M | +22% |
| Q4 2024 | $152.1M | +23% |
BRZE's revenue has grown year over year every quarter since early 2021: $227M last quarter, up 26% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -8% | +14 points |
| Q2 2026 | -13% | +12 points |
| Q1 2026 | -14% | -0.3 points |
| Q4 2025 | -20% | +1.8 points |
| Q3 2025 | -22% | -2.3 points |
| Q2 2025 | -25% | +4.8 points |
| Q1 2025 | -13% | +11 points |
| Q4 2024 | -21% | +6.9 points |
BRZE has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
BRZE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $23M | +431% |
| Q2 2026 | $28M | +17% |
| Q1 2026 | $14.6M | -9% |
| Q4 2025 | $19M | +$32.4M |
| Q3 2025 | $4.3M | -48% |
| Q2 2025 | $23.9M | +92% |
| Q1 2025 | $16M | +$18.5M |
| Q4 2024 | -$13.3M | -$8.3M |
BRZE has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
BRZE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +455K shares |
| 1 year | +4.2% | +4.4M shares |
| 3 years | +14% | +14.1M shares |
| 5 years | +23% | +21M shares |
| Available history | +554% | +94.2M shares |
BRZE has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $50M |
| Q3 2021 | $3,000 |
| Q2 2021 | — |
| Q1 2021 | $212,000 |
| Q4 2020 | $1,000 |
| Q3 2020 | $500 |
| Q2 2020 | $500 |
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BRZE Net Leverage
BRZE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
BRZE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 72.5 | Overbought |
| Stochastic | 98.9 | Overbought |
BRZE's weekly RSI is 73 (overbought) and its Stochastic is 99 (overbought).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
BRZE PE vs Technology Sector
BRZE has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
BRZE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.5 | 28% above |
| 20 week MA | $30.8 | 51% above |
| 50 week MA | $26.5 | 76% above |
| 100 week MA | $29.6 | 57% above |
| 200 week MA | $35.5 | 31% above |
BRZE has the edge over ASTS on trend strength, trading above more of its moving averages.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
BRZE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $94.2 | $77.2 | -18% |
| 2022 | $77.2 | $25.6 | -67% |
| 2023 | $25.6 | $53.1 | +108% |
| 2024 | $53.1 | $42.9 | -19% |
| 2025 | $42.9 | $35.4 | -17% |
| 2026 YTD | $35.4 | $46.6 | +32% |
BRZE has the edge over ASTS on returns for 2026, with the stronger performance.